A Study of Clinical Outcomes for the NanoString® Technologies Prosigna™ Gene Signature Assay
Clinical trial NCT02395575 · COMPLETED
Trial details
- NCT number
- NCT02395575
- Sponsor
- NanoString Technologies, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-03-01
- Primary completion
- 2016-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.